Inulin, a soluble fiber derived from chicory plants, received approval from the European Food Safety Authority as a food additive that stimulates release of glucagon-like peptide-1 (GLP-1), the hormone responsible for appetite suppression. The regulatory clearance clears the path for manufacturers to incorporate the compound into commercial food products within twelve months.
GLP-1 gained widespread public attention through injectable medications like semaglutide and tirzepatide, which have become blockbuster drugs for weight loss and diabetes management. Inulin offers a dietary alternative that triggers the same metabolic pathway through food rather than pharmaceutical injection.
The fiber works by feeding beneficial gut bacteria, which ferment inulin and produce short-chain fatty acids that signal intestinal cells to release GLP-1. This mechanism operates through the body's natural digestive processes, avoiding the need for repeated injections or prescriptions. Researchers identified the effect through controlled human studies examining how dietary fibers influence hormone secretion and metabolic response.
The EFSA's safety determination followed rigorous toxicology reviews and clinical evidence demonstrating that inulin consumption within recommended limits produces no adverse health effects. The approval applies specifically to inulin with a particular molecular weight and purity specification, narrowing its application to standardized formulations.
Food manufacturers can now explore incorporating inulin into bread, pasta, cereals, yogurt, and beverages marketed toward weight management or metabolic health. The additive's caloric contribution remains minimal, as humans cannot digest inulin efficiently, allowing it to pass through the digestive system largely unchanged while still triggering GLP-1 secretion.
This development represents a shift toward functional foods addressing obesity and metabolic disease. However, the GLP-1 response from dietary inulin remains modest compared to pharmaceutical GLP-1 agonists